/ /

LATEST

Patient educationIn our last article “Building a Patient Education Program” (May, page 82) we explored how a solid patient education program can keep patients, resources and revenue from falling through the cracks and what your practice needs to build a strong patient education program.
Do facial patches work?An old anti-aging concept was rediscovered with the renewed popularity of facial patches.
What are Korean facemasks?Korean facemasks are making their way from Asia to the US with great rapidity.
Do digital beauty advisor devices work?The digital beauty advisor is a digitized mirror providing personalized skin care information and day-to-day comparative health evaluations.
Fitting inThe approval of dupilumab (Dupixent, Sanofi Regeneron) for moderate-to-severe atopic dermatitis adds a much-needed option that may alter the broader course of atopic disease, experts told Dermatology Times.
East Asian patient concernsThere are both unique nuances and cultural considerations to rejuvenating the skin of East Asian patients, according to one dermatologist.
Revenue boostersDermatologists trying to boost practice revenue might add a device in hopes of making a profit on a cosmetic option or a skincare product line sold through the practice.
Considerations when treating children with lasersA laser is a suitable mode of treatment for certain dermatologic conditions in pediatric patients; however, there are certain procedural aspects that physicians should consider when treating younger children.
Pipeline topical reduces epidermolysis bullosa blisteringCastle Creek Pharmaceuticals announced in June 2017 that the first patient had enrolled in its phase 2/3 study assessing the safety and efficacy of its pipeline diacerein 1% ointment to treat epidermolysis bullosa simplex.
Adverse Reactions Associated with Biologics for Moderate-to-Severe Plaque Psoriasis
Adverse Reactions Associated with Biologics for Moderate-to-Severe Plaque PsoriasisIn July, our table of the month sums up biologics approved for moderate-to-severe plaque psoriasis and common adverse events associated with these biologics.

Poll

View Results